Newsletter
FDA Calendar
Market Data
Heat Map
Screener
Insider Trades
LOGIN
|
REGISTER
Index
Newsroom
Featured Stocks
Free Daily Newsletter
Stock Lists
See All Health Stock Lists
Biotechnology Stocks
Pharmaceutical Stocks
Big Pharma Stocks
Healthcare Stocks
Medical Stocks
Diagnostics & Research Stocks
Medical Device Stocks
Biotechnology News
Pharmaceutical News
Medical News
Healthcare News
Register
FDA Calendar
Market Data
Stock Screener
Insider Trades
Search
Logout
Newsroom
Featured Stocks
Stock Lists
Biotech
Pharma
Medical
Healthcare
Watch List
Recent Insider Transactions
Filter
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ
FDMT
4D Molecular Therapeutics
Bizily Scott
/
officer: Chief Legal Officer
11/17/2025
Sell
$10.59
1,635
$17K
3,594
NASDAQ
ADPT
Adaptive Biotechnologies
BENZENO SHARON
/
officer: Chief Commercial Ofc Imm Med
11/21/2025
Sell
$16.91
308,477
$5.216M
296,791
NASDAQ
ADPT
Adaptive Biotechnologies
BENZENO SHARON
/
officer: Chief Commercial Ofc Imm Med
11/20/2025
Sell
$16.54
297,925
$4.928M
296,791
NASDAQ
ADPT
Adaptive Biotechnologies
PISKEL KYLE
/
officer: Chief Financial Officer
11/17/2025
Sell
$14.05
238
$3K
269,343
NASDAQ
ADUS
Addus HomeCare
Anderson Darby
/
officer: EVP, Chief Govt Rel Officer
11/19/2025
Sell
$109.00
20,000
$2.180M
44,144
NASDAQ
ADMA
ADMA Biologics
Grossman Adam S
/
director, officer: President and CEO
11/19/2025
Sell
$16.00
15,000
$240K
2.02M
NASDAQ
ADMA
ADMA Biologics
Grossman Adam S
/
director, officer: President and CEO
11/19/2025
Sell
$16.00
6,000
$96K
2.01M
NASDAQ
ATEC
Alphatec
Lish Scott
/
officer: CHIEF OPERATING OFFICER
11/20/2025
Sell
$19.80
25,000
$495K
672,207
NASDAQ
ATEC
Alphatec
Marshall Tyson Eliot
/
officer: GENERAL COUNSEL & CORP. SEC.
11/20/2025
Sell
$19.51
70,000
$1.366M
368,331
NASDAQ
ALMS
Alumis
Foresite Labs, LLC
/
10 percent owner
11/19/2025
Buy
$6.56
190,500
$1.250M
2.54M
NASDAQ
ALMS
Alumis
Foresite Capital Management VI LLC
/
10 percent owner
11/18/2025
Buy
$6.19
117,374
$727K
2.35M
NASDAQ
ALMS
Alumis
Tananbaum James B.
/
director, 10 percent owner:
11/17/2025
Buy
$5.60
50,000
$280K
2.08M
NASDAQ
ALMS
Alumis
Foresite Capital Management VI LLC
/
10 percent owner
11/19/2025
Buy
$6.56
190,500
$1.250M
2.54M
NASDAQ
ALMS
Alumis
Tananbaum James B.
/
director, 10 percent owner:
11/17/2025
Buy
$5.59
150,000
$839K
2.23M
NASDAQ
ALMS
Alumis
Tananbaum James B.
/
director, 10 percent owner:
11/18/2025
Buy
$6.19
117,374
$727K
2.35M
NASDAQ
ALMS
Alumis
Foresite Labs, LLC
/
10 percent owner
11/17/2025
Buy
$5.60
50,000
$280K
2.08M
NASDAQ
ALMS
Alumis
AKKARAJU SRINIVAS
/
director
11/17/2025
Buy
$5.51
914
$5K
277,093
NASDAQ
ALMS
Alumis
Tananbaum James B.
/
director, 10 percent owner:
11/19/2025
Buy
$6.56
190,500
$1.250M
2.54M
NASDAQ
ALMS
Alumis
Foresite Labs, LLC
/
10 percent owner
11/17/2025
Buy
$5.59
150,000
$839K
2.23M
NASDAQ
ALMS
Alumis
AKKARAJU SRINIVAS
/
director
11/18/2025
Buy
$6.05
102,652
$621K
379,745
NASDAQ
ALMS
Alumis
Foresite Capital Management VI LLC
/
10 percent owner
11/17/2025
Buy
$5.60
50,000
$280K
2.08M
NASDAQ
ALMS
Alumis
Foresite Labs, LLC
/
10 percent owner
11/18/2025
Buy
$6.19
117,374
$727K
2.35M
NASDAQ
ALMS
Alumis
AKKARAJU SRINIVAS
/
director
11/19/2025
Buy
$6.56
137,772
$904K
517,517
NASDAQ
ALMS
Alumis
Foresite Capital Management VI LLC
/
10 percent owner
11/17/2025
Buy
$5.59
150,000
$839K
2.23M
NASDAQ
AMGN
Amgen
Grygiel Nancy A.
/
officer: SVP & CCO
11/20/2025
Sell
$337.26
1,639
$553K
7,225
NASDAQ
AMRX
Amneal Pharmaceuticals
Nark Ted C
/
director
11/17/2025
Sell
$11.72
50,000
$586K
291,029
NASDAQ
AMPH
Amphastar Pharmaceuticals
Petersen Floyd F.
/
director
11/13/2025
Sell
$26.49
16,679
$442K
75,531
NASDAQ
ANIP
ANI Pharmaceuticals
Walsh Patrick D
/
director
11/13/2025
Sell
$86.88
8,643
$751K
61,405
NASDAQ
ANNX
Annexon
Satter Muneer A
/
director
11/17/2025
Buy
$2.99
500,000
$1.495M
7.91M
NASDAQ
ANNX
Annexon
Satter Muneer A
/
director
11/18/2025
Buy
$3.18
500,000
$1.590M
8.41M
NASDAQ
ANNX
Annexon
Satter Muneer A
/
director
11/19/2025
Buy
$3.94
500,000
$1.970M
8.91M
NASDAQ
ANNX
Annexon
Satter Muneer A
/
director
11/20/2025
Buy
$4.48
400,000
$1.792M
9.31M
NASDAQ
ANNX
Annexon
Satter Muneer A
/
director
11/21/2025
Buy
$4.28
422,613
$1.809M
9.73M
NYSE
ANVS
Annovis Bio
Hoffman Michael B
/
director
11/21/2025
Buy
$3.50
10,000
$35K
2.49M
NYSE
ANVS
Annovis Bio
Hoffman Michael B
/
director
11/14/2025
Buy
$2.11
15,000
$32K
2.47M
NYSE
ANVS
Annovis Bio
Hoffman Michael B
/
director
11/21/2025
Buy
$3.49
10,000
$35K
2.48M
NASDAQ
APLS
Apellis Pharmaceuticals
Watson David O.
/
officer: General Counsel
11/17/2025
Sell
$20.06
5,000
$100K
108,730
NASDAQ
APGE
Apogee Therapeutics
Henderson Jane
/
officer: Chief Financial Officer
11/14/2025
Sell
$65.00
2,000
$130K
197,871
NASDAQ
ACLX
Arcellx
Heery Christopher
/
officer: CHIEF MEDICAL OFFICER
11/17/2025
Sell
$90.00
340
$31K
284
NASDAQ
ARQT
Arcutis Biotherapeutics
Krishnamohan Neha
/
director
11/13/2025
Sell
$23.37
1,232
$29K
22,123
NASDAQ
ARQT
Arcutis Biotherapeutics
Krishnamohan Neha
/
director
11/13/2025
Sell
$23.19
39,272
$911K
23,355
NASDAQ
SPRY
ARS Pharmaceuticals
Chakma Justin
/
officer: Chief Business Officer
11/12/2025
Sell
$8.86
136,380
$1.209M
0
NASDAQ
SPRY
ARS Pharmaceuticals
Chakma Justin
/
officer: Chief Business Officer
11/12/2025
Sell
$8.91
30,000
$267K
136,380
NASDAQ
SPRY
ARS Pharmaceuticals
Dorsey Brian
/
officer: Chief Operating Officer
11/13/2025
Sell
$8.71
21,828
$190K
10,789
NASDAQ
ARTV
Artiva Biotherapeutics
Aslan Fred
/
director, officer: President and CEO
11/17/2025
Sell
$3.38
6,375
$22K
343,999
NYSE
AORT
Artivion
Stanton Marshall S.
/
officer: SVP, Clinical & MD Affair
11/20/2025
Sell
$44.28
1,355
$60K
44,753
NYSE
AORT
Artivion
Stanton Marshall S.
/
officer: SVP, Clinical & MD Affair
11/20/2025
Sell
$44.32
2,033
$90K
44,753
NYSE
AORT
Artivion
Stanton Marshall S.
/
officer: SVP, Clinical & MD Affair
11/20/2025
Sell
$44.14
11,888
$525K
44,753
NASDAQ
ATRC
AtriCure
Yuen Maggie
/
director
11/21/2025
Sell
$35.72
3,000
$107K
11,371
NASDAQ
AURA
Aura Biosciences
Hopkins Janet Jill
/
officer: Chief Medical Officer
11/17/2025
Sell
$5.42
17,109
$93K
252,685
NASDAQ
AVTX
Avalo Therapeutics
Goldman Jonathan
/
director
11/14/2025
Sell
$14.35
8,200
$118K
0
NASDAQ
AVTX
Avalo Therapeutics
Goldman Jonathan
/
director
11/14/2025
Sell
$14.30
3,167
$45K
0
NASDAQ
BCRX
BioCryst Pharmaceuticals
SANDERS MACHELLE
/
director
11/13/2025
Sell
$7.14
9,600
$69K
30,642
NYSE
BHVN
Biohaven
CHILDS JOHN W
/
director
11/13/2025
Buy
$7.50
3.33M
$25.000M
5.65M
NYSE
BHVN
Biohaven
Bailey Gregory
/
director
11/13/2025
Buy
$7.50
400,000
$3.000M
2.02M
NYSE
BHVN
Biohaven
Coric Vlad
/
director, officer: Chief Executive Officer
11/13/2025
Buy
$7.50
333,333
$2.500M
740,546
NYSE
BHVN
Biohaven
Clark George C.
/
officer: VP, Chief Accounting Officer
11/17/2025
Buy
$8.52
17,000
$145K
20,000
NYSE
BHVN
Biohaven
Coric Vlad
/
director, officer: Chief Executive Officer
11/13/2025
Buy
$7.50
333,333
$2.500M
1.20M
OTCMKTS
BIXT
Bioxytran
Hoberman Alan M
/
director
11/18/2025
Buy
$0.60
210,000
$126K
210,000
NASDAQ
BBIO
BridgeBio Pharma
Trimarchi Thomas
/
officer: President and CFO
11/17/2025
Sell
$66.84
6,956
$465K
382,830
NASDAQ
BBIO
BridgeBio Pharma
Trimarchi Thomas
/
officer: President and CFO
11/17/2025
Sell
$66.19
9,978
$660K
389,786
NASDAQ
SAVA
Cassava Sciences
Barry Richard
/
director, officer: President & CEO
11/20/2025
Buy
$2.76
150,000
$414K
938,060
NASDAQ
CSTL
Castle Biosciences
MAETZOLD DEREK J
/
director, officer: Pres. & Chief Exec. Officer
11/18/2025
Sell
$34.02
2,678
$91K
50,937
NASDAQ
CSTL
Castle Biosciences
Juvenal Tobin W
/
officer: Chief Commercial Officer
11/20/2025
Sell
$35.58
4,693
$167K
84,595
NASDAQ
CELC
Celcuity
Dalvey David
/
director
11/21/2025
Sell
$100.00
15,000
$1.500M
110,000
NASDAQ
CELC
Celcuity
Buller Richard E
/
director
11/20/2025
Sell
$96.73
3,900
$377K
7,260
NASDAQ
CLDX
Celldex
Wright Richard M.
/
other: Former Officer
11/13/2025
Sell
$24.00
49,298
$1.183M
20,833
NASDAQ
CNTA
Centessa Pharmaceuticals
Bush Tia L
/
officer: Chief Technology & Quality Ofc
11/17/2025
Sell
$28.00
40,000
$1.120M
121,503
NASDAQ
CNTA
Centessa Pharmaceuticals
HUSSAIN IQBAL J
/
officer: General Counsel
11/17/2025
Sell
$27.64
6,000
$166K
105,386
NASDAQ
IPSC
Century Therapeutics
Cowan Chad
/
officer: Chief Scientific Officer
11/20/2025
Sell
$0.50
5,462
$3K
987,027
NASDAQ
IPSC
Century Therapeutics
Pfeiffenberger Brent
/
director, officer: President and CEO
11/17/2025
Sell
$0.45
32,456
$15K
3.24M
NASDAQ
CRVO
CervoMed
ALAM JOHN J
/
director, 10 percent owner, officer: CEO & President
11/13/2025
Buy
$7.51
4,447
$33K
1.47M
NASDAQ
CRVO
CervoMed
Winton Matthew
/
officer: Chief Commercial and Business
11/18/2025
Buy
$7.95
1,500
$12K
15,000
NASDAQ
CRVO
CervoMed
ALAM JOHN J
/
director, 10 percent owner, officer: CEO & President
11/14/2025
Buy
$7.55
1,693
$13K
1.47M
NASDAQ
CRVO
CervoMed
ELDER WILLIAM ROBERT
/
officer: CFO, GC & Secretary
11/17/2025
Buy
$8.45
1,000
$8K
10,000
NASDAQ
CRVO
CervoMed
Gregoire Sylvie
/
director, 10 percent owner:
11/14/2025
Buy
$7.55
1,693
$13K
1,693
NASDAQ
CRVO
CervoMed
ELDER WILLIAM ROBERT
/
officer: CFO, GC & Secretary
11/18/2025
Buy
$8.32
2,500
$21K
12,500
NASDAQ
CRVO
CervoMed
Gregoire Sylvie
/
director, 10 percent owner:
11/13/2025
Buy
$7.51
4,447
$33K
1.47M
NASDAQ
CRVO
CervoMed
Gregoire Sylvie
/
director, 10 percent owner:
11/17/2025
Buy
$8.46
10,807
$91K
12,500
NASDAQ
CRVO
CervoMed
Winton Matthew
/
officer: Chief Commercial and Business
11/14/2025
Buy
$7.57
10,000
$76K
10,000
NASDAQ
CRVO
CervoMed
Gregoire Sylvie
/
director, 10 percent owner:
11/14/2025
Buy
$7.57
1,707
$13K
1.47M
NASDAQ
CRVO
CervoMed
Gregoire Sylvie
/
director, 10 percent owner:
11/17/2025
Buy
$8.46
10,793
$91K
1.48M
NASDAQ
CRVO
CervoMed
ALAM JOHN J
/
director, 10 percent owner, officer: CEO & President
11/17/2025
Buy
$8.46
10,793
$91K
12,500
NASDAQ
CRVO
CervoMed
ALAM JOHN J
/
director, 10 percent owner, officer: CEO & President
11/14/2025
Buy
$7.57
1,707
$13K
1,707
NASDAQ
CRVO
CervoMed
Winton Matthew
/
officer: Chief Commercial and Business
11/17/2025
Buy
$8.43
3,500
$30K
13,500
NASDAQ
CRVO
CervoMed
ALAM JOHN J
/
director, 10 percent owner, officer: CEO & President
11/17/2025
Buy
$8.46
10,807
$91K
1.48M
NASDAQ
CGON
CG Oncology
POST LEONARD E
/
director
11/17/2025
Sell
$41.43
1,000
$41K
0
NYSE
CTEV
Claritev
O'Neil Tara
/
officer: SVP, General Counsel
11/17/2025
Buy
$38.84
625
$24K
25,028
NYSE
CTEV
Claritev
Kim Michael
/
officer: EVP, Chief Digital Officer
11/17/2025
Buy
$38.25
9,600
$367K
105,529
NASDAQ
CRMD
CorMedix
Dillione Janet
/
director
11/14/2025
Sell
$11.42
30,000
$343K
48,473
NASDAQ
COSM
Cosmos Health
Siokas Grigorios
/
director, 10 percent owner, officer: Chief Executive Officer
11/20/2025
Buy
$0.62
51,315
$32K
6.27M
NASDAQ
COSM
Cosmos Health
Siokas Grigorios
/
director, 10 percent owner, officer: Chief Executive Officer
11/19/2025
Buy
$0.65
61,614
$40K
6.22M
NASDAQ
CYTK
Cytokinetics
Malik Fady Ibraham
/
officer: EVP Research & Development
11/18/2025
Sell
$66.45
2,200
$146K
140,610
NASDAQ
DAWN
Day One Biopharmaceuticals
York Charles N II
/
officer: COO and CFO
11/17/2025
Sell
$8.91
4,062
$36K
294,715
NASDAQ
DAWN
Day One Biopharmaceuticals
Dubow Adam
/
officer: Gen Counsel & Secretary
11/17/2025
Sell
$8.91
4,319
$39K
62,626
NASDAQ
DAWN
Day One Biopharmaceuticals
Bender Jeremy
/
director, officer: CHIEF EXECUTIVE OFFICER
11/17/2025
Sell
$8.91
15,894
$142K
177,165
NASDAQ
DAWN
Day One Biopharmaceuticals
Merendino Lauren
/
officer: Chief Commercial Officer
11/17/2025
Sell
$8.91
3,726
$33K
50,809
NASDAQ
DXCM
DexCom
Collins Richard Alexander
/
director
11/14/2025
Sell
$59.05
2,906
$172K
35,088
NASDAQ
DNTH
Dianthus Therapeutics
Randhawa Simrat
/
officer: EVP, Head of R&D
11/13/2025
Sell
$35.80
26,166
$937K
65,341
NASDAQ
DNTH
Dianthus Therapeutics
Randhawa Simrat
/
officer: EVP, Head of R&D
11/14/2025
Sell
$38.14
109,031
$4.158M
4,000
NASDAQ
DNTH
Dianthus Therapeutics
Randhawa Simrat
/
officer: EVP, Head of R&D
11/13/2025
Sell
$37.72
18,576
$701K
4,000
NASDAQ
DNTH
Dianthus Therapeutics
Randhawa Simrat
/
officer: EVP, Head of R&D
11/13/2025
Sell
$37.04
42,765
$1.584M
22,576
NYSE
DOCS
Doximity
Cabral Timothy S
/
director
11/21/2025
Sell
$50.00
10,000
$500K
3,221
NYSE
LLY
Eli Lilly
LILLY ENDOWMENT INC
/
10 percent owner
11/14/2025
Sell
$1,032,320.00
17,567
$18.135B
92.88M
NYSE
LLY
Eli Lilly
LILLY ENDOWMENT INC
/
10 percent owner
11/14/2025
Sell
$1,031,410.00
55,908
$57.664B
92.90M
NYSE
LLY
Eli Lilly
LILLY ENDOWMENT INC
/
10 percent owner
11/14/2025
Sell
$1,030.31
103,871
$107.020M
92.96M
NYSE
LLY
Eli Lilly
LILLY ENDOWMENT INC
/
10 percent owner
11/21/2025
Sell
$1,052.36
2,885
$3.036M
92.59M
NYSE
LLY
Eli Lilly
LILLY ENDOWMENT INC
/
10 percent owner
11/21/2025
Sell
$1,051.48
5,506
$5.789M
92.59M
NYSE
LLY
Eli Lilly
LILLY ENDOWMENT INC
/
10 percent owner
11/21/2025
Sell
$1,050.27
9,871
$10.367M
92.60M
NYSE
LLY
Eli Lilly
LILLY ENDOWMENT INC
/
10 percent owner
11/14/2025
Sell
$1,033.16
949
$980K
92.88M
NASDAQ
ENSG
Ensign
Burton Spencer
/
officer: President and COO
11/20/2025
Sell
$180.00
3,690
$664K
51,165
NASDAQ
TRDA
Entrada Therapeutics
BAKER BROS. ADVISORS LP
/
10 percent owner
11/20/2025
Buy
$9.07
1,213
$11K
380,152
NASDAQ
TRDA
Entrada Therapeutics
BAKER BROS. ADVISORS LP
/
10 percent owner
11/20/2025
Buy
$9.07
1,186
$11K
381,338
NASDAQ
TRDA
Entrada Therapeutics
BAKER BROS. ADVISORS LP
/
10 percent owner
11/20/2025
Buy
$9.07
13,386
$121K
4.68M
NASDAQ
TRDA
Entrada Therapeutics
BAKER BROS. ADVISORS LP
/
10 percent owner
11/20/2025
Buy
$9.07
13,082
$119K
4.69M
NASDAQ
TRDA
Entrada Therapeutics
WENTWORTH KORY JAMES
/
officer: Chief Financial Officer
11/21/2025
Sell
$9.98
8,910
$89K
110,026
NYSE
EVH
Evolent Health
Springstubb Brendan B
/
director
11/18/2025
Buy
$3.82
10,000
$38K
58,821
NASDAQ
FENC
Fennec Pharmaceuticals
Southpoint Capital Advisors LP
/
10 percent owner
11/18/2025
Sell
$8.79
19,341
$170K
3.74M
NASDAQ
FENC
Fennec Pharmaceuticals
Southpoint Capital Advisors LP
/
10 percent owner
11/17/2025
Sell
$8.79
85,918
$755K
3.76M
NASDAQ
FENC
Fennec Pharmaceuticals
Southpoint Capital Advisors LP
/
10 percent owner
11/14/2025
Sell
$8.00
160,100
$1.280M
3.85M
NASDAQ
FULC
Fulcrum Therapeutics
Gould Robert J
/
director
11/19/2025
Sell
$11.03
15,000
$165K
484,864
NASDAQ
FLGT
Fulgent Genetics
Xie Jian
/
officer: President and COO
11/19/2025
Sell
$29.10
10,000
$291K
349,768
NASDAQ
GILD
Gilead Sciences
Mercier Johanna
/
officer: Chief Commercial Officer
11/17/2025
Sell
$126.26
2,476
$313K
107,193
NASDAQ
GILD
Gilead Sciences
Mercier Johanna
/
officer: Chief Commercial Officer
11/17/2025
Sell
$125.83
25,524
$3.212M
109,669
NASDAQ
GILD
Gilead Sciences
Dickinson Andrew D
/
officer: Chief Financial Officer
11/17/2025
Sell
$125.23
2,500
$313K
154,555
NYSE
GKOS
Glaukos
Gilliam Joseph E
/
officer: PRESIDENT & COO
11/18/2025
Sell
$90.00
19,340
$1.741M
92,366
NASDAQ
GRAL
GRAIL
ILLUMINA, INC.
/
10 percent owner
11/17/2025
Sell
$79.85
1,000,000
$79.850M
3.50M
NASDAQ
GH
Guardant Health
Tariq Musa
/
director
11/19/2025
Sell
$96.25
116
$11K
7,859
NYSE
HNGE
Hinge Health
Leslie Kristina M
/
director
11/21/2025
Sell
$45.68
1,250
$57K
27,750
NYSE
HNGE
Hinge Health
Pursley James
/
officer: President
11/21/2025
Sell
$46.09
2,954
$136K
789,902
NYSE
HNGE
Hinge Health
Pursley James
/
officer: President
11/21/2025
Sell
$45.75
9,332
$427K
792,856
NYSE
HNGE
Hinge Health
Pursley James
/
officer: President
11/21/2025
Sell
$44.35
2,714
$120K
802,190
NYSE
HNGE
Hinge Health
Budge James
/
officer: Chief Financial Officer
11/20/2025
Sell
$44.78
781
$35K
524,467
NYSE
HNGE
Hinge Health
Bessemer Venture Partners X L.P.
/
10 percent owner
11/18/2025
Sell
$40.05
725,000
$29.036M
3.38M
NASDAQ
IMVT
Immunovant
Gloria Melanie
/
officer: Chief Operating Officer
11/20/2025
Sell
$23.54
10,251
$241K
175,886
NASDAQ
IMVT
Immunovant
Gloria Melanie
/
officer: Chief Operating Officer
11/20/2025
Sell
$23.97
2,375
$57K
173,511
NASDAQ
INSM
Insmed
LEE LEO
/
director
11/17/2025
Sell
$196.61
24,076
$4.734M
69,851
NASDAQ
INSM
Insmed
LEE LEO
/
director
11/17/2025
Sell
$195.39
14,944
$2.920M
93,927
NASDAQ
INSM
Insmed
LEE LEO
/
director
11/17/2025
Sell
$194.49
17,594
$3.422M
108,871
NASDAQ
INSM
Insmed
LEE LEO
/
director
11/17/2025
Sell
$193.51
3,212
$622K
126,465
NASDAQ
INSM
Insmed
ANDERSON ELIZABETH M
/
director
11/14/2025
Sell
$195.87
10,000
$1.959M
63,729
NASDAQ
INSM
Insmed
LEE LEO
/
director
11/17/2025
Sell
$197.40
15,174
$2.995M
54,677
NASDAQ
IVVD
Invivyd
MCLAUGHLIN KEVIN F
/
director
11/19/2025
Buy
$2.50
50,000
$125K
50,000
NASDAQ
IRIX
Iridex
Dizon Romeo R
/
officer: Chief Financial Officer
11/17/2025
Buy
$0.96
3,034
$3K
79,753
NASDAQ
IRIX
Iridex
Dizon Romeo R
/
officer: Chief Financial Officer
11/18/2025
Buy
$0.94
2,133
$2K
81,976
NASDAQ
IRIX
Iridex
Dizon Romeo R
/
officer: Chief Financial Officer
11/17/2025
Buy
$0.96
90
$86
79,843
NASDAQ
IRIX
Iridex
Dizon Romeo R
/
officer: Chief Financial Officer
11/20/2025
Buy
$0.96
5,760
$6K
88,736
NASDAQ
IRIX
Iridex
Dizon Romeo R
/
officer: Chief Financial Officer
11/14/2025
Buy
$0.88
14,769
$13K
76,719
NASDAQ
ITRM
Iterum Therapeutics
Dunne Michael W.
/
director
11/18/2025
Buy
$0.37
6,000
$2K
241,001
NASDAQ
JANX
Janux Therapeutics
Meyer Andrew Hollman
/
officer: Chief Business Officer
11/14/2025
Sell
$30.00
3,333
$100K
84,974
NASDAQ
JAZZ
Jazz Pharmaceuticals
COZADD BRUCE C
/
director
11/18/2025
Sell
$180.88
8,382
$1.516M
397,060
NASDAQ
JAZZ
Jazz Pharmaceuticals
COZADD BRUCE C
/
director
11/18/2025
Sell
$180.09
3,384
$609K
405,442
NASDAQ
JAZZ
Jazz Pharmaceuticals
Iannone Robert
/
officer: EVP, Global Head of R&D & CMO
11/17/2025
Sell
$168.26
7,159
$1.205M
72,628
NASDAQ
JAZZ
Jazz Pharmaceuticals
COZADD BRUCE C
/
director
11/18/2025
Sell
$182.60
717
$131K
390,826
NASDAQ
JAZZ
Jazz Pharmaceuticals
COZADD BRUCE C
/
director
11/18/2025
Sell
$181.82
5,517
$1.003M
391,543
NASDAQ
KURA
Kura Oncology
Powl Brian T.
/
officer: Chief Commercial Officer
11/14/2025
Sell
$11.18
8,887
$99K
139,689
NASDAQ
KURA
Kura Oncology
Bair Teresa Brophy
/
officer: Chief Legal Officer
11/14/2025
Sell
$11.18
8,804
$98K
188,139
NASDAQ
KURA
Kura Oncology
FORD KATHLEEN
/
officer: Chief Operating Officer
11/14/2025
Sell
$11.18
6,902
$77K
105,373
NASDAQ
KURA
Kura Oncology
DOYLE THOMAS JAMES
/
officer: SVP, Finance & Accounting
11/14/2025
Sell
$11.18
4,539
$51K
130,257
NASDAQ
KURA
Kura Oncology
Leoni Mollie
/
officer: Chief Medical Officer
11/14/2025
Sell
$11.18
15,485
$173K
225,454
NASDAQ
LQDA
Liquidia
Adair Jason
/
officer: Chief Business Officer
11/18/2025
Sell
$30.03
35,656
$1.071M
174,998
NASDAQ
MNKD
MannKind
Singh Sanjay R
/
officer: EVP Technical Operations
11/14/2025
Sell
$5.03
18,777
$94K
455,211
TSX.V
MIR
MedMira
Kingsley Lawrence D
/
director
11/21/2025
Sell
$23.83
300,000
$7.148M
3.90M
NASDAQ
MEDP
Medpace
Troendle August J.
/
director, 10 percent owner, officer: CEO
11/21/2025
Sell
$592.18
21,858
$12.944M
833,627
NASDAQ
MEDP
Medpace
Troendle August J.
/
director, 10 percent owner, officer: CEO
11/19/2025
Sell
$592.07
23,862
$14.128M
862,315
NASDAQ
MEDP
Medpace
Troendle August J.
/
director, 10 percent owner, officer: CEO
11/20/2025
Sell
$598.49
6,830
$4.088M
855,485
NASDAQ
MEDP
Medpace
Troendle August J.
/
director, 10 percent owner, officer: CEO
11/18/2025
Sell
$590.84
7,191
$4.249M
886,177
NYSE
MDT
Medtronic
Smith Gregory L
/
officer: EVP Global Ops & Supply Chain
11/19/2025
Sell
$102.05
227
$23K
46,841
NYSE
MDT
Medtronic
Smith Gregory L
/
officer: EVP Global Ops & Supply Chain
11/19/2025
Sell
$102.04
825
$84K
47,068
NYSE
MDT
Medtronic
Smith Gregory L
/
officer: EVP Global Ops & Supply Chain
11/19/2025
Sell
$102.03
1,995
$204K
47,893
NYSE
MDT
Medtronic
Smith Gregory L
/
officer: EVP Global Ops & Supply Chain
11/19/2025
Sell
$101.99
1,942
$198K
49,888
NYSE
MDT
Medtronic
Smith Gregory L
/
officer: EVP Global Ops & Supply Chain
11/19/2025
Sell
$102.08
500
$51K
46,016
NYSE
MDT
Medtronic
Smith Gregory L
/
officer: EVP Global Ops & Supply Chain
11/19/2025
Sell
$101.93
24,186
$2.465M
51,830
NYSE
MDT
Medtronic
Smith Gregory L
/
officer: EVP Global Ops & Supply Chain
11/19/2025
Sell
$102.06
325
$33K
46,516
NASDAQ
MMSI
Merit Medical Systems
Lampropoulos Fred P.
/
director, officer: Executive Chairman
11/20/2025
Sell
$85.13
20,000
$1.703M
1.05M
NYSE
MTD
Mettler-Toledo
Keller Gerry
/
officer: Head of Process Analytics
11/21/2025
Sell
$1,418.58
236
$335K
159
NYSE
MOH
Molina Healthcare
Schapiro Richard M
/
director
11/24/2025
Sell
$143.02
357
$51K
11,352
NYSEAMEX
MYO
Myomo
KIRK THOMAS F
/
director
11/20/2025
Buy
$0.72
4,902
$4K
479,322
NYSEAMEX
MYO
Myomo
KIRK THOMAS F
/
director
11/21/2025
Buy
$0.72
2,535
$2K
481,857
NYSEAMEX
MYO
Myomo
Crowley Thomas Aloysius Jr.
/
director
11/19/2025
Buy
$0.77
385
$295
479
NYSEAMEX
MYO
Myomo
Crowley Thomas Aloysius Jr.
/
director
11/18/2025
Buy
$0.73
4,000
$3K
75,748
NASDAQ
NTRA
Natera
Baynes Roy D.
/
director
11/19/2025
Sell
$214.79
1,727
$371K
20,494
NASDAQ
NTRA
Natera
Sheena Jonathan
/
director, other: CO-FOUNDER
11/21/2025
Sell
$230.01
2,000
$460K
23,282
NASDAQ
NTRA
Natera
Baynes Roy D.
/
director
11/20/2025
Sell
$222.90
1,800
$401K
22,143
NASDAQ
NTRA
Natera
Sheena Jonathan
/
director, other: CO-FOUNDER
11/20/2025
Sell
$225.08
10,000
$2.251M
222,660
NASDAQ
NTRA
Natera
Baynes Roy D.
/
director
11/19/2025
Sell
$213.47
1,250
$267K
22,221
NASDAQ
NTRA
Natera
Baynes Roy D.
/
director
11/20/2025
Sell
$224.89
1,884
$424K
18,359
NASDAQ
NTRA
Natera
Baynes Roy D.
/
director
11/20/2025
Sell
$221.81
900
$200K
23,943
NASDAQ
NTRA
Natera
Baynes Roy D.
/
director
11/19/2025
Sell
$216.07
2,135
$461K
18,359
NASDAQ
NTRA
Natera
Baynes Roy D.
/
director
11/20/2025
Sell
$220.14
1,184
$261K
24,843
NASDAQ
NTRA
Natera
Baynes Roy D.
/
director
11/20/2025
Sell
$223.90
1,900
$425K
20,243
NASDAQ
NTRA
Natera
Sheena Jonathan
/
director, other: CO-FOUNDER
11/21/2025
Sell
$230.01
2,000
$460K
23,282
NASDAQ
NAGE
Niagen Bioscience
Pamir Ozan
/
officer: Chief Financial Officer
11/14/2025
Buy
$6.81
4,464
$30K
7,372
NASDAQ
NAGE
Niagen Bioscience
Pamir Ozan
/
officer: Chief Financial Officer
11/14/2025
Buy
$6.85
2,220
$15K
2,220
NYSE
NUVB
Nuvation Bio
Hattersley Gary
/
officer: CHIEF SCIENTIFIC OFFICER
11/20/2025
Sell
$7.23
300,000
$2.168M
0
NYSE
NUVB
Nuvation Bio
Liu Dongfang
/
officer: CHIEF MEDICAL OFFICER
11/20/2025
Sell
$7.00
20,000
$140K
18,000
NASDAQ
OMCL
Omnicell
Manley Corey J
/
officer: EVP&CHIEF LEGAL/ADMIN OFFICER
11/17/2025
Sell
$34.90
3,473
$121K
104,388
NASDAQ
OM
Outset Medical
Brottem John L.
/
officer: General Counsel
11/17/2025
Sell
$4.60
388
$2K
46,495
NYSEAMEX
CATX
Perspective Therapeutics
Hunt Jonathan Robert
/
officer: Chief Accounting Officer
11/13/2025
Buy
$2.03
11,000
$22K
59,800
NASDAQ
PAHC
Phibro Animal Health
BENDHEIM JACK
/
director, 10 percent owner, officer: President and CEO
11/20/2025
Sell
$41.75
3,459
$144K
46,221
NASDAQ
PAHC
Phibro Animal Health
BENDHEIM JACK
/
director, 10 percent owner, officer: President and CEO
11/18/2025
Sell
$43.82
5,260
$230K
49,700
NASDAQ
PAHC
Phibro Animal Health
BENDHEIM JACK
/
director, 10 percent owner, officer: President and CEO
11/17/2025
Sell
$44.56
5,280
$235K
54,960
NASDAQ
PAHC
Phibro Animal Health
BENDHEIM JACK
/
director, 10 percent owner, officer: President and CEO
11/20/2025
Sell
$42.32
61
$3K
46,160
NASDAQ
PAHC
Phibro Animal Health
BENDHEIM JACK
/
director, 10 percent owner, officer: President and CEO
11/18/2025
Sell
$44.28
20
$886
49,680
NASDAQ
PRAX
Praxis Precision Medicines
Nemiroff Alex
/
officer: General Counsel and Secretary
11/20/2025
Sell
$193.23
977
$189K
29,931
NASDAQ
PRAX
Praxis Precision Medicines
Nemiroff Alex
/
officer: General Counsel and Secretary
11/20/2025
Sell
$192.53
13,339
$2.568M
30,908
NASDAQ
PRAX
Praxis Precision Medicines
Nemiroff Alex
/
officer: General Counsel and Secretary
11/20/2025
Sell
$190.86
1,714
$327K
44,247
NASDAQ
PRAX
Praxis Precision Medicines
Mastrocola Lauren
/
officer: Principal Accounting Officer
11/20/2025
Sell
$192.71
2,145
$413K
10,441
NASDAQ
PRAX
Praxis Precision Medicines
Mastrocola Lauren
/
officer: Principal Accounting Officer
11/20/2025
Sell
$191.96
11,455
$2.199M
12,586
NASDAQ
PRAX
Praxis Precision Medicines
Nemiroff Alex
/
officer: General Counsel and Secretary
11/20/2025
Sell
$194.30
9,100
$1.768M
20,831
NASDAQ
PGEN
Precigen
KIRK RANDAL J
/
director, 10 percent owner:
11/21/2025
Sell
$3.83
937,308
$3.590M
5.55M
NASDAQ
PGEN
Precigen
KIRK RANDAL J
/
director, 10 percent owner:
11/20/2025
Sell
$4.08
942,832
$3.847M
6.49M
NASDAQ
PGEN
Precigen
KIRK RANDAL J
/
director, 10 percent owner:
11/19/2025
Sell
$4.47
1.09M
$4.855M
7.43M
NASDAQ
PRPO
Precipio
Sabet Ahmed Zaki
/
officer: Chief Operating Officer
10/01/2025
Buy
$19.50
25
$488
715
NASDAQ
PGNY
Progyny
Anevski Peter
/
director, officer: CHIEF EXECUTIVE OFFICER
11/13/2025
Buy
$24.29
79,500
$1.931M
680,251
NYSE
DGX
Quest Diagnostics
DELANEY MARK E
/
officer: SVP & Chief Commercial Officer
11/18/2025
Sell
$187.35
7,946
$1.489M
7,530
NASDAQ
QDEL
QuidelOrtho
Blaser Brian J.
/
officer: President and CEO
11/19/2025
Buy
$21.34
23,500
$502K
29,533
NASDAQ
QDEL
QuidelOrtho
POLAN MARY LAKE PH D
/
director
11/21/2025
Buy
$22.43
1,000
$22K
12,640
NASDAQ
RAPP
Rapport Therapeutics
Ceesay Abraham
/
director, officer: Chief Executive Officer
11/17/2025
Sell
$25.44
2,841
$72K
35,978
NASDAQ
RAPP
Rapport Therapeutics
Ceesay Abraham
/
director, officer: Chief Executive Officer
11/17/2025
Sell
$24.91
2,242
$56K
38,819
NASDAQ
RAPP
Rapport Therapeutics
Ceesay Abraham
/
director, officer: Chief Executive Officer
11/17/2025
Sell
$25.43
3,056
$78K
573,746
NASDAQ
RAPP
Rapport Therapeutics
Bredt David
/
officer: Chief Scientific Officer
11/17/2025
Sell
$25.39
5,344
$136K
401,142
NASDAQ
RAPP
Rapport Therapeutics
Ceesay Abraham
/
director, officer: Chief Executive Officer
11/17/2025
Sell
$24.92
2,777
$69K
576,802
NASDAQ
RAPP
Rapport Therapeutics
Bredt David
/
officer: Chief Scientific Officer
11/17/2025
Sell
$24.84
3,156
$78K
406,486
NASDAQ
REGN
Regeneron Pharmaceuticals
Bassler Bonnie L
/
director
11/20/2025
Sell
$750.00
760
$570K
1,548
NASDAQ
RGEN
Repligen
Bylund James
/
officer: Chief Operating Officer
11/18/2025
Sell
$151.21
2,191
$331K
21,520
NASDAQ
REPL
Replimune
Xynos Konstantinos
/
officer: Chief Medical Officer
11/17/2025
Sell
$9.10
7,248
$66K
139,685
NASDAQ
REPL
Replimune
Sarchi Christopher
/
officer: Chief Commercial Officer
11/17/2025
Sell
$9.10
5,208
$47K
123,088
NYSEAMEX
RVP
Retractable Technologies
SHAW THOMAS J
/
director, 10 percent owner, officer: PRESIDENT AND CEO
11/14/2025
Buy
$0.77
5,731
$4K
15.83M
NASDAQ
RVMD
Revolution Medicines
GOLDSMITH MARK A
/
director, officer: See Remarks
11/12/2025
Sell
$65.07
20,000
$1.301M
247,863
NASDAQ
RVMD
Revolution Medicines
Cislini Jeff
/
officer: General Counsel
11/18/2025
Sell
$70.14
13,388
$939K
50,425
NASDAQ
RVMD
Revolution Medicines
GOLDSMITH MARK A
/
director, officer: See Remarks
11/18/2025
Sell
$70.38
20,000
$1.408M
247,863
NASDAQ
RYTM
Rhythm Pharmaceuticals
Cramer Pamela J.
/
officer: Chief Human Resources Officer
11/20/2025
Sell
$105.00
3,350
$352K
20,814
NASDAQ
RCKT
Rocket Pharmaceuticals
Shah Gaurav
/
director, officer: CEO
11/18/2025
Sell
$2.98
6,276
$19K
778,296
NASDAQ
RCKT
Rocket Pharmaceuticals
Schwartz Jonathan David
/
officer: See Remarks
11/18/2025
Sell
$2.98
2,545
$8K
299,064
NASDAQ
RMTI
Rockwell Medical
COOPER JOHN G
/
director
11/18/2025
Sell
$0.87
5,079
$4K
140,372
NASDAQ
ROIV
Roivant
QVT Financial LP
/
other: Director by Deputization
11/19/2025
Sell
$20.25
850,000
$17.213M
18.50M
NASDAQ
ROIV
Roivant
MANCHESTER KEITH S
/
director
11/19/2025
Sell
$20.16
125,000
$2.520M
18.22M
NASDAQ
ROIV
Roivant
Ramaswamy Vivek
/
10 percent owner
11/13/2025
Sell
$20.81
287,283
$5.978M
35.22M
NASDAQ
ROIV
Roivant
Gold Daniel Allen
/
director
11/19/2025
Sell
$20.24
175,000
$3.542M
18.05M
NASDAQ
ROIV
Roivant
MANCHESTER KEITH S
/
director
11/19/2025
Sell
$20.20
150,000
$3.030M
18.35M
NASDAQ
ROIV
Roivant
Gold Daniel Allen
/
director
11/19/2025
Sell
$20.16
125,000
$2.520M
18.22M
NASDAQ
ROIV
Roivant
MANCHESTER KEITH S
/
director
11/19/2025
Sell
$20.25
850,000
$17.213M
18.50M
NASDAQ
ROIV
Roivant
QVT Financial LP
/
other: Director by Deputization
11/19/2025
Sell
$20.24
175,000
$3.542M
18.05M
NASDAQ
ROIV
Roivant
Gold Daniel Allen
/
director
11/19/2025
Sell
$20.20
150,000
$3.030M
18.35M
NASDAQ
ROIV
Roivant
Gold Daniel Allen
/
director
11/19/2025
Sell
$20.25
850,000
$17.213M
18.50M
NASDAQ
ROIV
Roivant
Ramaswamy Vivek
/
10 percent owner
11/17/2025
Sell
$20.51
539,650
$11.068M
33.65M
NASDAQ
ROIV
Roivant
QVT Financial LP
/
other: Director by Deputization
11/19/2025
Sell
$20.16
125,000
$2.520M
18.22M
NASDAQ
ROIV
Roivant
QVT Financial LP
/
other: Director by Deputization
11/19/2025
Sell
$20.20
150,000
$3.030M
18.35M
NASDAQ
ROIV
Roivant
MANCHESTER KEITH S
/
director
11/19/2025
Sell
$20.24
175,000
$3.542M
18.05M
NASDAQ
ROIV
Roivant
Ramaswamy Vivek
/
10 percent owner
11/14/2025
Sell
$20.33
1.03M
$20.893M
34.19M
NASDAQ
SLS
SELLAS Life Sciences
Kalin Katherine Bach
/
director
11/19/2025
Buy
$1.59
63,400
$101K
104,400
NASDAQ
SRTS
Sensus Healthcare
Sardano Michael
/
director, officer: PRESIDENT AND GENERAL COUNSEL
11/18/2025
Buy
$3.80
1,000
$4K
118,839
NASDAQ
SRTS
Sensus Healthcare
Sardano Michael
/
director, officer: PRESIDENT AND GENERAL COUNSEL
11/11/2025
Buy
$4.27
766
$3K
766
NASDAQ
SRTS
Sensus Healthcare
Sardano Joseph C
/
director, officer: CHIEF EXECUTIVE OFFICER
11/18/2025
Buy
$4.03
25,000
$101K
1.20M
NASDAQ
SRTS
Sensus Healthcare
Sardano Michael
/
director, officer: PRESIDENT AND GENERAL COUNSEL
11/11/2025
Buy
$4.34
234
$1K
1,000
NASDAQ
MCRB
Seres Therapeutics
Shaff Eric D.
/
director
11/15/2025
Sell
$17.30
217
$4K
11,113
NASDAQ
MCRB
Seres Therapeutics
Henn Matthew R
/
officer: See Remarks
11/15/2025
Sell
$17.30
1,257
$22K
7,527
NASDAQ
MCRB
Seres Therapeutics
Young Teresa L.
/
officer: See Remarks
11/15/2025
Sell
$17.30
1,042
$18K
8,401
NASDAQ
MCRB
Seres Therapeutics
DesRosier Thomas
/
officer: See Remarks
11/15/2025
Sell
$17.30
76
$1K
7,623
NASDAQ
SGHT
Sight Sciences
HAYDEN JEREMY B.
/
officer: Chief Legal Officer
11/12/2025
Sell
$8.01
3,150
$25K
256,590
NASDAQ
SLGL
Sol-Gel Technologies
Opaleye Management Inc.
/
10 percent owner
11/20/2025
Buy
$35.83
5,784
$207K
363,151
NASDAQ
STAA
STAAR Surgical
BROADWOOD PARTNERS, L.P.
/
10 percent owner
11/19/2025
Buy
$26.42
309,132
$8.166M
13.83M
NASDAQ
STAA
STAAR Surgical
BROADWOOD PARTNERS, L.P.
/
10 percent owner
11/20/2025
Buy
$27.14
393,382
$10.675M
14.22M
NASDAQ
STAA
STAAR Surgical
BROADWOOD PARTNERS, L.P.
/
10 percent owner
11/21/2025
Buy
$27.86
797,486
$22.219M
15.02M
NASDAQ
LAB
Standard BioTools
Casdin Partners Master Fund, L.P.
/
director, 10 percent owner:
11/13/2025
Buy
$1.20
450,000
$541K
62.50M
NASDAQ
LAB
Standard BioTools
Casdin Partners Master Fund, L.P.
/
director, 10 percent owner:
11/14/2025
Buy
$1.24
250,000
$310K
62.75M
NASDAQ
LAB
Standard BioTools
Casdin Partners Master Fund, L.P.
/
director, 10 percent owner:
11/19/2025
Buy
$1.28
350,000
$449K
63.60M
NASDAQ
LAB
Standard BioTools
Casdin Partners Master Fund, L.P.
/
director, 10 percent owner:
11/20/2025
Buy
$1.30
450,000
$586K
64.05M
NASDAQ
LAB
Standard BioTools
Casdin Partners Master Fund, L.P.
/
director, 10 percent owner:
11/17/2025
Buy
$1.22
225,000
$276K
62.98M
NASDAQ
LAB
Standard BioTools
Casdin Partners Master Fund, L.P.
/
director, 10 percent owner:
11/18/2025
Buy
$1.23
275,000
$339K
63.25M
NYSE
STE
STERIS
Tamaro Renato
/
officer: V.P. & Corporate Treasurer
11/18/2025
Sell
$257.76
1,500
$387K
5,695
NYSE
STE
STERIS
Tamaro Renato
/
officer: V.P. & Corporate Treasurer
11/18/2025
Sell
$258.03
212
$55K
7,195
NYSE
STE
STERIS
Tamaro Renato
/
officer: V.P. & Corporate Treasurer
11/18/2025
Sell
$257.43
3,324
$856K
7,407
NASDAQ
STOK
Stoke Therapeutics
Krainer Adrian R.
/
director
11/14/2025
Sell
$27.34
20,682
$565K
364,246
NASDAQ
STOK
Stoke Therapeutics
Krainer Adrian R.
/
director
11/14/2025
Sell
$26.61
19,790
$527K
384,928
NASDAQ
SSKN
STRATA Skin Sciences
Rubinstein Samuel
/
director
11/17/2025
Sell
$1.34
7,200
$10K
5,160
NASDAQ
SSKN
STRATA Skin Sciences
Rubinstein Samuel
/
director
11/18/2025
Buy
$1.40
2,168
$3K
5,934
NASDAQ
SSKN
STRATA Skin Sciences
Rubinstein Samuel
/
director
11/18/2025
Buy
$1.41
2,832
$4K
8,766
NASDAQ
SSKN
STRATA Skin Sciences
Rubinstein Samuel
/
director
11/17/2025
Sell
$1.32
5,500
$7K
12,360
NASDAQ
SSKN
STRATA Skin Sciences
Rubinstein Samuel
/
director
11/17/2025
Sell
$1.36
1,394
$2K
3,766
NYSE
SYK
Stryker
Berry William E Jr
/
officer: VP, Chief Accounting Officer
11/14/2025
Sell
$365.49
1,953
$714K
2,833
NYSE
SYK
Stryker
Wells Preston Wendell
/
officer: VP, Chief Financial Officer
11/20/2025
Sell
$365.88
165
$60K
6,694
NASDAQ
SRZN
Surrozen
COLUMN GROUP III GP, LP
/
10 percent owner
11/13/2025
Buy
$12.65
148,150
$1.874M
852,482
NASDAQ
SRZN
Surrozen
COLUMN GROUP III GP, LP
/
10 percent owner
11/13/2025
Buy
$12.65
167,307
$2.116M
962,718
NASDAQ
TELA
TELA Bio
EW HEALTHCARE PARTNERS FUND 2, L.P.
/
10 percent owner, other: See Remarks
11/17/2025
Buy
$1.11
3.60M
$4.000M
7.71M
NYSE
TDOC
Teladoc Health
Paulus Kenneth H
/
director
11/14/2025
Buy
$6.94
10,000
$69K
10,000
NASDAQ
TEM
Tempus AI
LEFKOFSKY ERIC P
/
director, 10 percent owner, officer: CEO and Chairman
11/20/2025
Sell
$66.33
6,467
$429K
9.06M
NASDAQ
TEM
Tempus AI
LEFKOFSKY ERIC P
/
director, 10 percent owner, officer: CEO and Chairman
11/20/2025
Sell
$71.63
8,841
$633K
9.05M
NASDAQ
TEM
Tempus AI
Phelps Erik
/
officer: EVP & Chief Admin & Legal Off
11/18/2025
Sell
$65.26
2,428
$158K
91,687
NASDAQ
TEM
Tempus AI
LEFKOFSKY ERIC P
/
director, 10 percent owner, officer: CEO and Chairman
11/20/2025
Sell
$68.38
3,640
$249K
16.78M
NASDAQ
TEM
Tempus AI
Polovin Andrew
/
officer: EVP and General Counsel
11/18/2025
Sell
$65.26
3,578
$234K
128,478
NASDAQ
TEM
Tempus AI
Bartolucci Ryan M
/
officer: Chief Accounting Officer
11/18/2025
Sell
$66.15
573
$38K
44,061
NASDAQ
TEM
Tempus AI
LEFKOFSKY ERIC P
/
director, 10 percent owner, officer: CEO and Chairman
11/20/2025
Sell
$65.59
6,221
$408K
9.07M
NASDAQ
TEM
Tempus AI
Polovin Andrew
/
officer: EVP and General Counsel
11/19/2025
Sell
$69.41
200
$14K
120,464
NASDAQ
TEM
Tempus AI
LEFKOFSKY ERIC P
/
director, 10 percent owner, officer: CEO and Chairman
11/20/2025
Sell
$67.39
7,660
$516K
16.78M
NASDAQ
TEM
Tempus AI
LEFKOFSKY ERIC P
/
director, 10 percent owner, officer: CEO and Chairman
11/20/2025
Sell
$70.58
3,074
$217K
9.05M
NASDAQ
TEM
Tempus AI
Rogers James William
/
officer: Chief Financial Officer
11/18/2025
Sell
$66.15
2,269
$150K
131,216
NASDAQ
TEM
Tempus AI
LEFKOFSKY ERIC P
/
director, 10 percent owner, officer: CEO and Chairman
11/20/2025
Sell
$72.20
15,138
$1.093M
16.70M
NASDAQ
TEM
Tempus AI
Polovin Andrew
/
officer: EVP and General Counsel
11/19/2025
Sell
$68.86
2,052
$141K
120,664
NASDAQ
TEM
Tempus AI
LEFKOFSKY ERIC P
/
director, 10 percent owner, officer: CEO and Chairman
11/20/2025
Sell
$66.33
25,866
$1.716M
16.79M
NASDAQ
TEM
Tempus AI
Bartolucci Ryan M
/
officer: Chief Accounting Officer
11/18/2025
Sell
$65.26
1,261
$82K
44,634
NASDAQ
TEM
Tempus AI
LEFKOFSKY ERIC P
/
director, 10 percent owner, officer: CEO and Chairman
11/20/2025
Sell
$69.43
2,041
$142K
9.06M
NASDAQ
TEM
Tempus AI
Rogers James William
/
officer: Chief Financial Officer
11/18/2025
Sell
$65.26
4,988
$326K
133,485
NASDAQ
TEM
Tempus AI
LEFKOFSKY ERIC P
/
director, 10 percent owner, officer: CEO and Chairman
11/20/2025
Sell
$65.59
24,881
$1.632M
16.81M
NASDAQ
TEM
Tempus AI
Fukushima Ryan
/
officer: Chief Operating Officer
11/18/2025
Sell
$66.15
3,157
$209K
829,081
NASDAQ
TEM
Tempus AI
LEFKOFSKY ERIC P
/
director, 10 percent owner, officer: CEO and Chairman
11/20/2025
Sell
$71.63
35,362
$2.533M
16.72M
NASDAQ
TEM
Tempus AI
Polovin Andrew
/
officer: EVP and General Counsel
11/19/2025
Sell
$67.90
3,307
$225K
122,716
NASDAQ
TEM
Tempus AI
LEFKOFSKY ERIC P
/
director, 10 percent owner, officer: CEO and Chairman
11/18/2025
Sell
$66.15
5,262
$348K
2.00M
NASDAQ
TEM
Tempus AI
LEFKOFSKY ERIC P
/
director, 10 percent owner, officer: CEO and Chairman
11/20/2025
Sell
$68.38
910
$62K
9.06M
NASDAQ
TEM
Tempus AI
LEFKOFSKY ERIC P
/
director, 10 percent owner, officer: CEO and Chairman
11/18/2025
Sell
$65.26
11,567
$755K
2.01M
NASDAQ
TEM
Tempus AI
Fukushima Ryan
/
officer: Chief Operating Officer
11/18/2025
Sell
$65.26
6,942
$453K
832,238
NASDAQ
TEM
Tempus AI
LEFKOFSKY ERIC P
/
director, 10 percent owner, officer: CEO and Chairman
11/20/2025
Sell
$70.58
12,295
$868K
16.75M
NASDAQ
TEM
Tempus AI
Polovin Andrew
/
officer: EVP and General Counsel
11/19/2025
Sell
$66.40
828
$55K
126,023
NASDAQ
TEM
Tempus AI
LEFKOFSKY ERIC P
/
director, 10 percent owner, officer: CEO and Chairman
11/20/2025
Sell
$67.39
1,913
$129K
9.06M
NASDAQ
TEM
Tempus AI
LEFKOFSKY ERIC P
/
director, 10 percent owner, officer: CEO and Chairman
11/20/2025
Sell
$72.20
3,783
$273K
9.04M
NASDAQ
TEM
Tempus AI
Phelps Erik
/
officer: EVP & Chief Admin & Legal Off
11/18/2025
Sell
$66.15
1,105
$73K
90,582
NASDAQ
TEM
Tempus AI
LEFKOFSKY ERIC P
/
director, 10 percent owner, officer: CEO and Chairman
11/20/2025
Sell
$69.43
8,158
$566K
16.77M
NASDAQ
TEM
Tempus AI
Polovin Andrew
/
officer: EVP and General Counsel
11/18/2025
Sell
$66.15
1,627
$108K
126,851
NASDAQ
TENX
Tenax Therapeutics
Giordano Christopher Thomas
/
director, officer: CEO
11/18/2025
Buy
$7.75
1,612
$13K
1,612
NASDAQ
TENX
Tenax Therapeutics
Giordano Christopher Thomas
/
director, officer: CEO
11/19/2025
Buy
$7.51
455
$3K
2,067
NASDAQ
TENX
Tenax Therapeutics
Giordano Christopher Thomas
/
director, officer: CEO
11/20/2025
Buy
$7.59
538
$4K
2,605
NASDAQ
TNYA
Tenaya Therapeutics
Higa Tomohiro
/
officer: SVP, Finance
11/17/2025
Sell
$1.33
1,367
$2K
93,971
NASDAQ
TNYA
Tenaya Therapeutics
Ali Faraz
/
director, officer: Chief Executive Officer
11/17/2025
Sell
$1.33
3,126
$4K
299,666
NASDAQ
TNYA
Tenaya Therapeutics
Tingley Whittemore
/
officer: Chief Medical Officer
11/17/2025
Sell
$1.33
2,877
$4K
169,926
NASDAQ
TNON
Tenon Medical
Grawey Nathaniel A.
/
officer: Chief Commercial Officer
11/14/2025
Buy
$1.16
101,167
$117K
101,167
NASDAQ
TNON
Tenon Medical
Geist Wyatt D.
/
officer: Chief Innovation Officer
11/14/2025
Buy
$1.16
19,455
$23K
19,455
NASDAQ
TNON
Tenon Medical
FOSTER STEVEN M
/
director, officer: CEO and President
11/14/2025
Buy
$1.16
19,455
$23K
19,455
NYSE
TEVA
Teva Pharmaceutical
Fox Christine
/
officer: EVP, Head of U.S. Commercial
11/20/2025
Sell
$24.78
28,229
$700K
63,647
NASDAQ
TMDX
TransMedics
Hassanein Waleed H
/
director, officer: President & CEO
11/17/2025
Buy
$114.00
8,775
$1.000M
495,009
NASDAQ
TBRG
TruBridge
Pinetree Capital Ltd.
/
10 percent owner
11/13/2025
Buy
$20.41
21,035
$429K
798,220
NASDAQ
TBRG
TruBridge
Daughton Michael
/
officer: Chief Business Officer
11/11/2025
Buy
$19.39
15,479
$300K
22,971
NASDAQ
TBRG
TruBridge
Pinetree Capital Ltd.
/
10 percent owner
11/14/2025
Buy
$20.23
18,933
$383K
817,153
NASDAQ
TBRG
TruBridge
Daughton Michael
/
officer: Chief Business Officer
11/12/2025
Buy
$19.95
10,167
$203K
33,138
NASDAQ
TBRG
TruBridge
Daughton Michael
/
officer: Chief Business Officer
11/13/2025
Buy
$20.16
4,354
$88K
37,492
NASDAQ
TBRG
TruBridge
Daughton Michael
/
officer: Chief Business Officer
11/14/2025
Buy
$20.15
2,500
$50K
39,992
NASDAQ
TBRG
TruBridge
Pinetree Capital Ltd.
/
10 percent owner
11/19/2025
Buy
$20.52
5,000
$103K
2.00M
NASDAQ
TBRG
TruBridge
Daughton Michael
/
officer: Chief Business Officer
11/17/2025
Buy
$20.46
17,500
$358K
57,492
NASDAQ
TBRG
TruBridge
Pinetree Capital Ltd.
/
10 percent owner
11/12/2025
Buy
$19.94
8,935
$178K
777,185
NASDAQ
TYRA
Tyra Biosciences
Bensen Daniel
/
officer: Chief Operating Officer
11/13/2025
Sell
$16.00
1,111
$18K
426,870
NASDAQ
TYRA
Tyra Biosciences
Bensen Daniel
/
officer: Chief Operating Officer
11/17/2025
Sell
$17.07
1,500
$26K
296,570
NASDAQ
TYRA
Tyra Biosciences
Bensen Daniel
/
officer: Chief Operating Officer
11/17/2025
Sell
$16.11
18,572
$299K
298,070
NASDAQ
TYRA
Tyra Biosciences
Bensen Daniel
/
officer: Chief Operating Officer
11/14/2025
Sell
$16.02
110,228
$1.765M
316,642
NYSE
USPH
U.S. Physical Therapy
Gilmartin Kathleen A
/
director
11/20/2025
Buy
$69.00
4,000
$276K
24,786
NASDAQ
UTHR
United Therapeutics
EDGEMOND JAMES
/
officer: CFO AND TREASURER
11/17/2025
Sell
$470.34
437
$206K
8,118
NASDAQ
UTHR
United Therapeutics
EDGEMOND JAMES
/
officer: CFO AND TREASURER
11/17/2025
Sell
$471.22
2,657
$1.252M
12,558
NASDAQ
UTHR
United Therapeutics
EDGEMOND JAMES
/
officer: CFO AND TREASURER
11/17/2025
Sell
$475.89
798
$380K
8,202
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: Chairperson & CEO
11/18/2025
Sell
$472.60
1,000
$473K
1,630
NASDAQ
UTHR
United Therapeutics
EDGEMOND JAMES
/
officer: CFO AND TREASURER
11/17/2025
Sell
$468.33
4,107
$1.923M
13,113
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: Chairperson & CEO
11/19/2025
Sell
$474.22
2,000
$948K
2,130
NASDAQ
UTHR
United Therapeutics
EDGEMOND JAMES
/
officer: CFO AND TREASURER
11/17/2025
Sell
$469.39
4,558
$2.139M
8,555
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: Chairperson & CEO
11/18/2025
Sell
$470.53
1,500
$706K
2,630
NASDAQ
UTHR
United Therapeutics
EDGEMOND JAMES
/
officer: CFO AND TREASURER
11/17/2025
Sell
$470.34
3,591
$1.689M
15,215
NASDAQ
UTHR
United Therapeutics
EDGEMOND JAMES
/
officer: CFO AND TREASURER
11/17/2025
Sell
$474.80
639
$303K
9,000
NASDAQ
UTHR
United Therapeutics
EDGEMOND JAMES
/
officer: CFO AND TREASURER
11/17/2025
Sell
$467.53
1,090
$510K
17,220
NASDAQ
UTHR
United Therapeutics
EDGEMOND JAMES
/
officer: CFO AND TREASURER
11/17/2025
Sell
$473.68
920
$436K
9,639
NASDAQ
UTHR
United Therapeutics
EDGEMOND JAMES
/
officer: CFO AND TREASURER
11/17/2025
Sell
$464.38
120
$56K
18,310
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: Chairperson & CEO
11/19/2025
Sell
$474.95
2,000
$950K
130
NASDAQ
UTHR
United Therapeutics
EDGEMOND JAMES
/
officer: CFO AND TREASURER
11/17/2025
Sell
$476.47
84
$40K
8,118
NASDAQ
UTHR
United Therapeutics
EDGEMOND JAMES
/
officer: CFO AND TREASURER
11/17/2025
Sell
$472.13
1,999
$944K
10,559
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: Chairperson & CEO
11/18/2025
Sell
$475.10
1,500
$713K
130
NASDAQ
VCYT
Veracyte
Holstein Jens
/
director
11/20/2025
Sell
$43.21
1,460
$63K
27,199
NASDAQ
VCYT
Veracyte
Holstein Jens
/
director
11/20/2025
Sell
$42.48
7,049
$299K
28,659
NASDAQ
VCYT
Veracyte
Holstein Jens
/
director
11/20/2025
Sell
$40.95
1,491
$61K
35,708
NASDAQ
VRTX
Vertex Pharmaceuticals
LEIDEN JEFFREY M
/
director, officer: Executive Chairman
11/14/2025
Sell
$442.00
40
$18K
24,026
NASDAQ
VRTX
Vertex Pharmaceuticals
LEIDEN JEFFREY M
/
director, officer: Executive Chairman
11/13/2025
Sell
$441.05
1,160
$512K
24,026
NASDAQ
VRTX
Vertex Pharmaceuticals
LEIDEN JEFFREY M
/
director, officer: Executive Chairman
11/14/2025
Sell
$441.35
21,330
$9.414M
24,066
NASDAQ
VRTX
Vertex Pharmaceuticals
LEIDEN JEFFREY M
/
director, officer: Executive Chairman
11/13/2025
Sell
$440.22
18,528
$8.156M
25,186
NASDAQ
VRTX
Vertex Pharmaceuticals
LEIDEN JEFFREY M
/
director, officer: Executive Chairman
11/14/2025
Sell
$440.30
32,234
$14.193M
45,396
NYSE
RBOT
Vicarious Surgical
Khalifa Sammy
/
director, 10 percent owner, officer: Chief Technology Officer
11/20/2025
Sell
$2.74
653
$2K
33,862
NYSE
RBOT
Vicarious Surgical
Sachs Adam David
/
director, 10 percent owner, officer: President
11/20/2025
Sell
$2.72
816
$2K
48,348
NASDAQ
VANI
Vivani Medical
Williams Gregg
/
director, 10 percent owner:
11/15/2025
Buy
$1.12
1.47M
$1.650M
22.82M
NASDAQ
VANI
Vivani Medical
Williams Gregg
/
director, 10 percent owner:
11/15/2025
Buy
$1.26
264,550
$333K
23.09M
OTCMKTS
RDGL
Vivos
Korenko Michael K
/
director, officer: CEO AND PRESIDENT
11/20/2025
Buy
$0.06
100,000
$6K
10.64M
NASDAQ
WVE
Wave Life Sciences
RA CAPITAL MANAGEMENT, L.P.
/
director, 10 percent owner:
11/13/2025
Buy
$6.69
1,000
$7K
18.20M
NASDAQ
WVE
Wave Life Sciences
Rawcliffe Adrian
/
director
11/13/2025
Sell
$6.79
16,115
$109K
12,700
NASDAQ
WAY
Waystar
Sinclair III Eric L. (Ric)
/
officer: Chief Business Officer
11/20/2025
Sell
$35.27
9,701
$342K
474,826
NASDAQ
HOWL
Werewolf Therapeutics
GADICKE ANSBERT
/
10 percent owner
11/13/2025
Sell
$0.98
90,951
$89K
5.60M
NASDAQ
HOWL
Werewolf Therapeutics
EVNIN LUKE
/
director
11/13/2025
Sell
$0.98
58,372
$57K
3.59M
NASDAQ
HOWL
Werewolf Therapeutics
MPM BioVentures 2014, L.P.
/
10 percent owner
11/17/2025
Sell
$0.95
57,061
$54K
5.48M
NASDAQ
HOWL
Werewolf Therapeutics
MPM BioVentures 2014, L.P.
/
10 percent owner
11/14/2025
Sell
$0.93
61,640
$57K
5.54M
NASDAQ
HOWL
Werewolf Therapeutics
MPM BioVentures 2014, L.P.
/
10 percent owner
11/13/2025
Sell
$0.98
90,951
$89K
5.60M
NASDAQ
HOWL
Werewolf Therapeutics
GADICKE ANSBERT
/
10 percent owner
11/17/2025
Sell
$0.95
57,061
$54K
5.48M
NASDAQ
HOWL
Werewolf Therapeutics
EVNIN LUKE
/
director
11/17/2025
Sell
$0.95
36,621
$35K
3.52M
NASDAQ
HOWL
Werewolf Therapeutics
GADICKE ANSBERT
/
10 percent owner
11/14/2025
Sell
$0.93
61,640
$57K
5.54M
NASDAQ
HOWL
Werewolf Therapeutics
EVNIN LUKE
/
director
11/14/2025
Sell
$0.93
39,560
$37K
3.55M
NASDAQ
XERS
Xeris Biopharma
Shannon John Patrick Jr
/
director, officer: See Remarks
11/13/2025
Sell
$7.46
23,242
$173K
2.64M
Research Tools
Stock Screener
FDA Catalyst Calendar
Insider Transactions
Life Science Stock Lists
All Life Science Stocks
News & Announcements
All Life Science News
Clinical Trial News
Company FDA Updates
Mergers & Acquisitions
Search News & Events
Popular Topics
Top Stocks in 2025
Big Pharma Stocks
Artificial Intelligence
Obesity Drugs
Psychedelic Stocks
Miscellaneous
Free Daily Newsletter
Follow Us On X
Advertise
Privacy Policy
Disclaimer
Tweet
Share
Share
Share
Share
Sign Up To Get Daily
Life Science News
Register
or
Login
to Access Entire Platform.
